Molecular Data Inc (MKD) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MKD Annual Cash Flow →
From Molecular Data Inc through 0, changes in Jun 30 2021's operating cash flow provide insight into underlying business performance trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2021)
6 Months
(Dec 31 2020) 0 0 0
Operating Activities
Income-5.03
Depreciation & amortization0.05
Amortization of Other Assets0.87
Increase (Decrease) in Deferred Revenue-2.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.22
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation2.26
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.30
Non Cash Lease Expense Of Right Of Use Assets-
Accounts Receivable Credit Loss-
Impairment Of Investments-
Increase Decrease In Contract With Customer Asset-
Increase Decrease In Deferred Government Grants-
Increase Decrease In Lease Liabilities-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.44
Increase (Decrease) in Accounts Payable, Trade10.00
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities2.95
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets10.77
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.04
Payments for (Proceeds from) Other Operating Activities-24.77
Discontinued operations0.00
Net Cash flow from Operating Activities-3.92
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Payments to Acquire Short-term Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments To Acquire Property Plant And Equipment Net-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Long-term Investments-0.53
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.53
Financing Activities
Short-term debt Net0.37
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-3.09
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock7.51
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Proceeds From Deemed Contribution To Shareholders-
Proceeds From Capital Contribution To Equity-
Restricted Cash Current-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.78
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-3.92
Total Cash Flow0.29
4 historic quarters locked

Sign in to unlock the full Molecular Data Inc cash flow history.

About MKD Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.